Intralesional interferon in the treatment of Peyronie's disease: a pilot study
The DOI matches its Crossref record.
Abstract
Objective To investigate the effect of intralesional interferon on patients with severe Peyronie's disease. Patients and methods Thirteen patients with Peyronie's disease and associated penile deformity of greater than 12 months' duration were selected. Characteristics of the plaque and the degree of deformity were measured objectively. Ten patients received 1.5 MU of α2B‐interferon intralesionally three times a week for 3 weeks. Three patients received similar volumes of intralesional saline. Results Six of the 10 patients who received interferon reported the complete disappearance of pain on erection and an improvement in the penile deformity. Although the objective improvement in deformity was relatively small, with a mean improvement of 20°, patients with a small plaque (<4 cm) had a better response. All those receiving inferferon had predictable but brief side‐effects similar to the symptoms of influenza. Conclusion Intralesional interferon is safe and well tolerated and results in symptomatic and some objective improvement, especially in patients with smaller Peyronie's plaques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hellstrom, W. J. G., Kendirci, M., Matern, R., Cockerham, Y., Myers, L., Sikka, S. C., Venable, D., Honig, S., McCullough, A., Hakim, L. S., et al. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00517-9 · Cited by 223
Peyronie's Disease: Etiology, Medical, and Surgical Therapy
HELLSTROM, W. J. G., & BIVALACQUA, T. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03387.x · Cited by 170
Role of oxidative stress and antioxidants in Peyronie’s disease
Sikka, S. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900880 · Cited by 77
Paulis, G., & Brancato, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812798889321 · Cited by 60
“In most of studies interferon alfa-2a (IFN- -2b) was used (intralesional injection) [66, 67]; only one study was performed (not placebo-controlled) with IFN- -2a [68].”
Method
Metadata
- Authors
- Judge, J. S., & Wisniewski, Z. S.
- Venue
- British Journal of Urology
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 79
- Issue
- 1
- Pages
- 40-42
- ISSN
- 0007-1331 (ISSN-L)
- OpenAlex
- W2095739037
- Cited by
- 67
- References
- 0
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intralesional interferon in the treatment of Peyronie's disease: a pilot study. https://app.cochat.ai/papers/10.1046/j.1464-410x.1997.02849.x
- The paper
- Judge, J. S., & Wisniewski, Z. S. (1997). Intralesional interferon in the treatment of Peyronie's disease: a pilot study. British Journal of Urology. https://doi.org/10.1046/j.1464-410x.1997.02849.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.